Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/13774
Type
ArticleCopyright
Restricted access
Collections
- IOC - Artigos de Periódicos [12828]
Metadata
Show full item record
LAMININ THERAPY FOR THE PROMOTION OF MUSCLE REGENERATION
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa sobre o Timo. Rio de Janeiro, RJ, Brasil / Sorbonne Universities. Pierre and Marie Curie University. Fiocruz Inserm UPMC International Associated Laboratory on Cell Therapy and Immunotherapy. Paris, France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa sobre o Timo. Rio de Janeiro, RJ, Brasil / Sorbonne Universities. Pierre and Marie Curie University. Fiocruz Inserm UPMC International Associated Laboratory on Cell Therapy and Immunotherapy. Paris, France / Fundação Oswaldo Cruz. Programa de Pesquisa sobre o Câncer. Rio de Janeiro, RJ, Brasil.
Sorbonne Universities. Pierre and Marie Curie University. Fiocruz Inserm UPMC International Associated Laboratory on Cell Therapy and Immunotherapy. Paris, France / Sorbonne Universities. Pierre and Marie Curie University. Center of Research in Myology. Paris, France / INSERM U974. Paris, France / CNRS-FRE 3617. Paris, France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa sobre o Timo. Rio de Janeiro, RJ, Brasil / Sorbonne Universities. Pierre and Marie Curie University. Fiocruz/Inserm/UPMC International Associated Laboratory on Cell Therapy and Immunotherapy. Paris, France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa sobre o Timo. Rio de Janeiro, RJ, Brasil / Sorbonne Universities. Pierre and Marie Curie University. Fiocruz Inserm UPMC International Associated Laboratory on Cell Therapy and Immunotherapy. Paris, France / Fundação Oswaldo Cruz. Programa de Pesquisa sobre o Câncer. Rio de Janeiro, RJ, Brasil.
Sorbonne Universities. Pierre and Marie Curie University. Fiocruz Inserm UPMC International Associated Laboratory on Cell Therapy and Immunotherapy. Paris, France / Sorbonne Universities. Pierre and Marie Curie University. Center of Research in Myology. Paris, France / INSERM U974. Paris, France / CNRS-FRE 3617. Paris, France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa sobre o Timo. Rio de Janeiro, RJ, Brasil / Sorbonne Universities. Pierre and Marie Curie University. Fiocruz/Inserm/UPMC International Associated Laboratory on Cell Therapy and Immunotherapy. Paris, France.
Abstract
Muscle regeneration is essentially due to activation of satellite cells, which can be isolated and amplified ex vivo, thus representing good candidates for cell therapy. Accumulating data show that the local microenvironment plays a major role during muscle regeneration. In the satellite cell niche, a major extracellular matrix protein is laminin. Human myoblasts transplanted into immunodeficient mice are preferentially located in laminin-enriched areas. Additionally, laminin-111 enhances myoblast proliferation in vitro and increases expression of the α7β1 integrin-type laminin receptor. Intramuscular injection of laminin-111 ameliorates muscular pathology in mdx mice, protecting muscle fibers from damage. Moreover, transplantation of human myoblasts with laminin-111 into Rag/mdx immunodeficient recipients improved efficacy of myoblast transplantation, increasing the number of human dystrophin-positive myofibres. Taken together, these data strongly indicate that exogenous laminin can ameliorate the regeneration process in different models of muscular dystrophies and can be instrumental for improving cell therapy aiming at repairing the degeneration/regeneration process in skeletal muscle.
Share